Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.
Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies
AI-human collaboration in a “Virtual Lab” successfully designs and experimentally validates nanobodies with enhanced binding to SARS-CoV-2 variants, offering a novel approach to interdisciplinary research.